Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition
Jesse N. Clark(University of California, Los Angeles), Catherine Orrell(South African Medical Research Council), Avi Kenny(University of Washington), Kelly E. Seaton(International Vaccine Institute), David C. Montefiori(Duke University), Nyaradzo Mgodi(University of Zimbabwe), Michal Juraska(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Yunda Huang(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Srilatha Edupuganti(Emory University), Raabya Rossenkhan(Fred Hutch Cancer Center), Caroline Brackett(Duke University), James I. Mullins(University of Washington), Paul T. Edlefsen(Fred Hutch Cancer Center), Allan C. deCamp(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Georgia D. Tomaras(National Institutes of Health), April K. Randhawa(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Michelle Rojas(Center for Human Genetics), Lynn Morris(National Health Laboratory Service), Carolyn Williamson(National Health Laboratory Service), Lu Zhang(Kunming Institute of Zoology), Myron S. Cohen(University of North Carolina at Chapel Hill), Erika Rudnicki(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Fatima Laher(University of the Witwatersrand), Marcella Sarzotti‐Kelsoe(Duke Medical Center), Lawrence Corey(Fred Hutch Cancer Center), Heather Angier(Fred Hutch Cancer Center), Nicole L. Yates(Duke University), Shelly Karuna(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Ian Frank(Norwegian Womens Public Health Association), Jack Heptinstall(Duke University), Joshua A. Weiner(Dartmouth College), John R. Mascola(National Institute of Allergy and Infectious Diseases), Margaret E. Ackerman(Dartmouth College), José A. Hidalgo(Via Libre), Kelvin Chiong(Duke University), Peter B. Gilbert(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Elena E. Giorgi(Fred Hutch Cancer Center), P. Andrew(Family Health International 360), Mark Sampson(Center for Human Genetics), Lily Zhang(Fred Hutch Cancer Center), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Sheetal Sawant(Duke University), M J McElrath(Fred Hutch Cancer Center), Adrian B. McDermott
Cited by 0
Related Papers
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
|New England Journal of Medicine|1990|1.3k